{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:30Z","timestamp":1792788150786,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Start Plan of the Eighth Affiliated Hospital, Southern Medical University","award":["SRSP2025005"],"award-info":[{"award-number":["SRSP2025005"]}]},{"name":"Medical Research Project of Foshan Municipal Health Bureau","award":["202632044012"],"award-info":[{"award-number":["202632044012"]}]},{"name":"National Natural Science Foundation of China","award":["82472120, 82103404"],"award-info":[{"award-number":["82472120, 82103404"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-05062-1","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:23:24Z","timestamp":1788747804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sprayable hydrogel loaded with engineered fusion cellular vesicles for cancer recurrence suppression"],"prefix":"10.1186","volume":"24","author":[{"given":"Yumiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingluo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1642-3924","authenticated-orcid":false,"given":"Guangtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"5062_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41467-024-55068-2","volume":"16","author":"C Wang","year":"2025","unstructured":"Wang C, Li J, Chen J, Wang Z, Zhu G, Song L, et al. Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer. Nat Commun. 2025;16:1477.","journal-title":"Nat Commun"},{"key":"5062_CR2","doi-asserted-by":"publisher","first-page":"e222422","DOI":"10.1148\/radiol.222422","volume":"307","author":"S Park","year":"2023","unstructured":"Park S, Lee SM, Choe J, Choi S, Do KH, Seo JB. Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT. Radiology. 2023;307:e222422.","journal-title":"Radiology"},{"key":"5062_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.actbio.2024.01.037","volume":"177","author":"J Gui","year":"2024","unstructured":"Gui J, Zhu Y, Chen X, Gong T, Zhang Z, Yu R, et al. Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis. Acta Biomater. 2024;177:388\u201399.","journal-title":"Acta Biomater"},{"key":"5062_CR4","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1038\/s41467-022-32787-y","volume":"13","author":"L Ding","year":"2022","unstructured":"Ding L, Fu Y, Zhu N, Zhao M, Ding Z, Zhang X, et al. OXTR(High) stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling. Nat Commun. 2022;13:5124.","journal-title":"Nat Commun"},{"key":"5062_CR5","first-page":"e2309053","volume":"11","author":"L Chen","year":"2024","unstructured":"Chen L, Yin Q, Zhang H, Zhang J, Yang G, Weng L, et al. Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11:e2309053.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"5062_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat reviews Disease primers. 2020;6:92.","journal-title":"Nat reviews Disease primers"},{"key":"5062_CR7","doi-asserted-by":"publisher","first-page":"216043","DOI":"10.1016\/j.canlet.2022.216043","volume":"559","author":"Q Wang","year":"2023","unstructured":"Wang Q, Qin Y, Li B. CD8(+) T cell exhaustion and cancer immunotherapy. Cancer Lett. 2023;559:216043.","journal-title":"Cancer Lett"},{"key":"5062_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance. Annu Rev Pathol. 2021;16:223\u201349.","journal-title":"Annu Rev Pathol"},{"key":"5062_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol. 2022;19:775\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"5062_CR10","first-page":"83","volume":"22","author":"M Zhao","year":"2025","unstructured":"Zhao M, Schoenfeld JD, Egloff AM, Hanna GJ, Haddad RI, Adkins DR, et al. T cell dynamics with neoadjuvant immunotherapy in head and neck cancer. Nature reviews. Clin Oncol. 2025;22:83\u201394.","journal-title":"Clin Oncol"},{"key":"5062_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","volume":"14","author":"M Nishino","year":"2017","unstructured":"Nishino M, Ramaiya NH, Hatabu H, Hodi FS. Monitoring immune-checkpoint blockade: response evaluation and biomarker development. Nat Rev Clin Oncol. 2017;14:655\u201368.","journal-title":"Nat Rev Clin Oncol"},{"key":"5062_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","volume":"18","author":"Z Zheng","year":"2019","unstructured":"Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, et al. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8\u2009+\u2009T cells. Mol Cancer. 2019;18:54.","journal-title":"Mol Cancer"},{"key":"5062_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s40425-019-0770-2","volume":"7","author":"S Chen","year":"2019","unstructured":"Chen S, Crabill GA, Pritchard TS, McMiller TL, Wei P, Pardoll DM, et al. Mechanisms regulating PD-L1 expression on tumor and immune cells. J Immunother Cancer. 2019;7:305.","journal-title":"J Immunother Cancer"},{"key":"5062_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","volume":"26","author":"Q Sun","year":"2026","unstructured":"Sun Q, Dong C. Regulators of CD8(+) T cell exhaustion. Nat Rev Immunol. 2026;26:129\u201351.","journal-title":"Nat Rev Immunol"},{"key":"5062_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"HR Jin","year":"2023","unstructured":"Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16:103.","journal-title":"J Hematol Oncol"},{"key":"5062_CR16","doi-asserted-by":"crossref","unstructured":"Manzo T, Prentice BM, Anderson KG, Raman A, Schalck A, Codreanu GS et al. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8\u2009+\u2009T cells. J Exp Med. 2020;217:e20191920.","DOI":"10.1084\/jem.20191920"},{"key":"5062_CR17","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.plipres.2022.101193","volume":"88","author":"Y Li","year":"2022","unstructured":"Li Y, Huang X, Yang G, Xu K, Yin Y, Brecchia G, et al. CD36 favours fat sensing and transport to govern lipid metabolism. Prog Lipid Res. 2022;88:101193.","journal-title":"Prog Lipid Res"},{"key":"5062_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metabol. 2021;33:1001\u2013e10125.","journal-title":"Cell Metabol"},{"key":"5062_CR19","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu S, Chaudhary O, Rodr\u00edguez-Morales P, Sun X, Chen D, Zappasodi R, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8\u2009+\u2009T cells in tumors. Immunity. 2021;54:1561\u2013e15777.","journal-title":"Immunity"},{"key":"5062_CR20","doi-asserted-by":"publisher","first-page":"9581","DOI":"10.1002\/adma.201602173","volume":"28","author":"H Sun","year":"2016","unstructured":"Sun H, Su J, Meng Q, Yin Q, Chen L, Gu W, et al. Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors. Adv Mater (Deerfield Beach Fla). 2016;28:9581\u20138.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"5062_CR21","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1021\/acsnano.7b08355","volume":"12","author":"D Wang","year":"2018","unstructured":"Wang D, Dong H, Li M, Cao Y, Yang F, Zhang K, et al. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal\/Chemotherapy of Melanoma. ACS Nano. 2018;12:5241\u201352.","journal-title":"ACS Nano"},{"key":"5062_CR22","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1038\/s41467-024-50021-9","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Wu H, Yu Z, Wang Q, Zeng X, Qian W, et al. Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery. Nat Commun. 2024;15:5689.","journal-title":"Nat Commun"},{"key":"5062_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-024-01859-4","volume":"9","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu Q, Wang M, Li L, Yu Y, Pan M, et al. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer. Signal Transduct Target therapy. 2024;9:158.","journal-title":"Signal Transduct Target Ther"},{"key":"5062_CR24","first-page":"e2302131","volume":"10","author":"Q Cheng","year":"2023","unstructured":"Cheng Q, Kang Y, Yao B, Dong J, Zhu Y, He Y, et al. Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2023;10:e2302131.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"5062_CR25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nmat4707","volume":"15","author":"J Conde","year":"2016","unstructured":"Conde J, Oliva N, Zhang Y, Artzi N. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat Mater. 2016;15:1128\u201338.","journal-title":"Nat Mater"},{"key":"5062_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H, et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol. 2019;14:89\u201397.","journal-title":"Nat Nanotechnol"},{"key":"5062_CR27","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1021\/acsnano.2c09893","volume":"17","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang C, Wu B, Li C, Lin J, Huang P. Thermoresponsive Ozone-Enriched Spray Gel for Postsurgical Treatment of Hepatocellular Carcinoma. ACS Nano. 2023;17:3518\u201327.","journal-title":"ACS Nano"},{"key":"5062_CR28","first-page":"e2004853","volume":"32","author":"L Rao","year":"2020","unstructured":"Rao L, Zhao SK, Wen C, Tian R, Lin L, Cai B, et al. Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles. Advanced materials (Deerfield Beach. Fla). 2020;32:e2004853.","journal-title":"Fla)"},{"key":"5062_CR29","doi-asserted-by":"publisher","first-page":"26320","DOI":"10.1002\/anie.202108342","volume":"60","author":"QF Meng","year":"2021","unstructured":"Meng QF, Zhao Y, Dong C, Liu L, Pan Y, Lai J, et al. Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy. Angew Chem Int Ed Engl. 2021;60:26320\u20136.","journal-title":"Angew Chem Int Ed Engl"},{"key":"5062_CR30","first-page":"e2311702","volume":"20","author":"C Zhao","year":"2024","unstructured":"Zhao C, Pan Y, Liu L, Zhang J, Wu X, Liu Y, et al. Hybrid Cellular Nanovesicles Block PD-L1 Signal and Repolarize M2 Macrophages for Cancer Immunotherapy. Small (Weinheim an der Bergstrasse. Germany). 2024;20:e2311702.","journal-title":"Germany)"},{"key":"5062_CR31","first-page":"0697","volume":"8","author":"B Li","year":"2025","unstructured":"Li B, Cui H, Liu W, Lan Z, Liu C, Yang Y, et al. DDX10 Exacerbates Exosomal PD-L1-Dependent T Cell Exhaustion via Phase Separation of Rab27b in Oral Squamous Cell Carcinoma. Res (Washington D C). 2025;8:0697.","journal-title":"Res (Washington D C)"},{"key":"5062_CR32","doi-asserted-by":"crossref","unstructured":"Cheng G, Wu J, Liu W, Yang Y, Cui H, Dai X et al. A customized immunomodulator reinforces the T cell-mediated immunological cascade for cancer therapy. Chem Eng J 2025;522:167231.","DOI":"10.1016\/j.cej.2025.167231"},{"key":"5062_CR33","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1038\/s41467-020-18626-y","volume":"11","author":"L Rao","year":"2020","unstructured":"Rao L, Wu L, Liu Z, Tian R, Yu G, Zhou Z, et al. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nat Commun. 2020;11:4909.","journal-title":"Nat Commun"},{"key":"5062_CR34","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","volume":"181","author":"KJ Oestreich","year":"2008","unstructured":"Oestreich KJ, Yoon H, Ahmed R, Boss JM. NFATc1 regulates PD-1 expression upon T cell activation. J Immunol (Baltimore Md : 1950). 2008;181:4832\u20139.","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"5062_CR35","doi-asserted-by":"publisher","first-page":"12632","DOI":"10.1038\/ncomms12632","volume":"7","author":"CW Li","year":"2016","unstructured":"Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7:12632.","journal-title":"Nat Commun"},{"key":"5062_CR36","doi-asserted-by":"publisher","first-page":"e2412253","DOI":"10.1002\/adma.202412253","volume":"36","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zou Y, Sun H, He Y, Ye K, Li Y, et al. Engineered Enucleated Mesenchymal Stem Cells Regulating Immune Microenvironment and Promoting Wound Healing. Adv Mater (Deerfield Beach Fla). 2024;36:e2412253.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"5062_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-024-02198-2","volume":"24","author":"MA Freitas-Cortez","year":"2025","unstructured":"Freitas-Cortez MA, Masrorpour F, Jiang H, Mahmud I, Lu Y, Huang A, et al. Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Mol Cancer. 2025;24:40.","journal-title":"Mol Cancer"},{"key":"5062_CR38","doi-asserted-by":"publisher","first-page":"eado3485","DOI":"10.1126\/sciimmunol.ado3485","volume":"10","author":"J Liang","year":"2025","unstructured":"Liang J, Liao J, Chang R, Jia W, Li G, Chen Z, et al. Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma. Sci Immunol. 2025;10:eado3485.","journal-title":"Sci Immunol"},{"key":"5062_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H Lin","year":"2024","unstructured":"Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17:31.","journal-title":"J Hematol Oncol"},{"key":"5062_CR40","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, et al. Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385.","journal-title":"Cancer Discov"},{"key":"5062_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41419-025-07593-1","volume":"16","author":"D Peng","year":"2025","unstructured":"Peng D, Yang W, Tang T, He A, Xu X, Jing T, et al. PLA2G7 promotes immune evasion of bladder cancer through the JAK-STAT-PDL1 axis. Cell Death Dis. 2025;16:234.","journal-title":"Cell Death Dis"},{"key":"5062_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.actbio.2024.04.025","volume":"180","author":"H Cui","year":"2024","unstructured":"Cui H, Zhao YY, Han YH, Lan Z, Zou KL, Cheng GW, et al. Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1. Acta Biomater. 2024;180:423\u201335.","journal-title":"Acta Biomater"},{"key":"5062_CR43","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.7150\/thno.41498","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, Li J, Li Q, Wang X, Medikonda R, Zhao T, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10:5943\u201356.","journal-title":"Theranostics"},{"key":"5062_CR44","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","volume":"48","author":"C Wang","year":"2018","unstructured":"Wang C, Guan Y, Lv M, Zhang R, Guo Z, Wei X, et al. Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses. Immunity. 2018;48:675\u2013e6877.","journal-title":"Immunity"},{"key":"5062_CR45","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1111\/odi.14925","volume":"30","author":"H Chen","year":"2024","unstructured":"Chen H, Cui H, Liu W, Li BW, Tian Z, Zhao YY, et al. Manganese drives ferroptosis of cancer cells via YAP\/TAZ phase separation activated ACSL4 in OSCC. Oral Dis. 2024;30:4898\u2013908.","journal-title":"Oral Dis"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-05062-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-05062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-05062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:36:55Z","timestamp":1789976215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-05062-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5062"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-05062-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"1 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was conducted in strict compliance with the guidelines approved by the Institutional Animal Care and Ethics Committee of Southern Medical University. The study had received formal ethical approval from the Institutional Ethics Review Committee (NYKQ-LAEC-2025-017). This study did not include human subjects; therefore, informed consent was not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"883"}}